T cell antigen receptor gene and application thereof
A technology of receptor gene and cell antigen, applied in the field of genetic engineering, can solve the problem of off-target effect of antigen receptor
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] Example 1, Design and Construction of CAR-EGFR
[0033] 1-1. Design description of CAR. According to statistics, the CAR structures most used in clinical trials include second-generation and third-generation CARs (see attached figure 1 ), among the relevant clinical reports, there are many second-generation CARs, especially the CAR structure led by the University of Pennsylvania (NCT01626495, NCT01029366), so we adopted this second-generation CAR frame structure.
[0034] 1-2. The structure and construction of CAR. The CAR-EGFR sequence includes the following parts: CD8-pre, EGFR-scFv, CD8 hinge + transmembrane, 4-1BB (CD137), CD3ζ. See SEQ ID NO: 1 for its complete sequence.
[0035] 1-3. The structure and construction of the CAR control group. The sequence structure of CAR-control group includes: CD8-pre, EGFR-scFv, CD8-ΔCD3ζ. See SEQ ID NO:2 for its complete sequence.
Embodiment 2
[0036] Example 2. Preparation and phenotypic verification of CAR-EGFR modified T cells (CART-EGFR)
[0037] 2-1. Preparation of CART-EGFR and CART-control group. The preparation process of CART-EGFR and CART-control group is attached figure 2 shown. Specifically include the following:
[0038] 2-1-1. Experimental reagents and experimental instruments:
[0039] Experimental reagents include:
[0040] Ficoll-PaquePLUS (GE, cat#17-1440-02)
[0041] Complete medium TexMACS (MiltenyiBiotechnolog, cat#170-076-309)+IL-2 (MiltenyiBiotechnolog, cat#130-097-748)
[0042] PerCP5.5 anti-human CD3 (BD, cat#552852)
[0043] PEanti-human CD4 (BD, cat#555347)
[0044] APCanti-humanCD8 (BD, cat#555369)
[0045] FACS buffer: PBS+2.5%FBS
[0046] TRANSB.
[0047] Experimental equipment includes:
[0048] Centrifuge: Xiangyi L550
[0049] Flow cytometer: BDC6
[0050] CO2 incubator: ESCOMCO-20AIC
[0051] Cell counter: Cellometer Auto1000.
[0052] 2-1-2. PBMC separation: transfer...
Embodiment 3
[0066] Example 3. Functional verification of CART-EGFR—verification of target cells
[0067] Experimental purpose: To detect the expression of EGFR on target cells and non-target cells. Experimental design: The target cells (Eca109) and control cells (MCF7) were detected using the flow cytometry antibody of EGFR. Experimental results and analysis: The results of flow cytometry detection of Eca109 and MCF7EGFR expression are as follows: Image 6 , the results showed that the expression of EGFR was low in the negative control MCF7, but the expression of EGFR was high in the target cell Eca109.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com